［1］Blom JW，Doggen CJ，Osanto S，et al．Malignancies prothrombotic mutations and the risk of venous thrombosis［J］．JAMA，2005，293(6)：715-722．
［2］Yin Minyi，Jiang Mier，Li Weimin，et al.Early and midterm outcomes of acute lower extremity deep venous thrombosistreated by catheter directed thrombolysis［J］.J Shanghai Jiaotong University(Medical Science），2011，31（12）：1741-1745.［殷敏毅，蒋米尔，李维敏，等.导管溶栓术治疗急性下肢深静脉血栓形成的早中期疗效［J］.上海交通大学学报（医学版），2011，31（12）：1741-1745.］
［3］Kearon C，Akl EA，Comerota AJ，et al.Antithrombotic therapy for VTE disease：Antithrombotic therapy and prevention of thrombosis，9 th ed：American college of chest physicians evidence-based clinical practice guidelines［J］.Chest，2012，141(2 Suppl)：419-494.
［4］Porter JM，Moneta GL.International consensus committee on chronic venous disease，reporting standards in venous disease：an update［J］.J Vasc Surg，1995:635-645.
［5］Mewissen MW，Swabrook GR，Meissner MH，et al.Catheter-directed thrombolysis for lower extremity deep venousthrombosis：report of a national multicenter registry［J］.Radiology，1999，211：39-49.
［6］Heit JA，Silverstein MD，Mohr DN，et al.Risk factors for deep vein thrombosis and pulmonary embolism：a p［olulation-based case-control study［J］.Arch Intern Med，2000，160(6)：809-815.
［7］Alikhan R，Cohen AT，Combe S，et al.Risk factors for venous thromboembolism in hospitalized patients with acute medical illness：analysis of the MEDENOX study［J］.Arch Intern Med，2004，164(9)：963-968.
［8］Spencer FA，Lessard D，Emery C，et al.Clinical characteristics and management of cancer-associated acute venous thromboembolism in the outpatient setting［J］.Arch Intern Med，2007，167(14)：1471-1475.
［9］Imberti D，Anelli G，Ageno W，et al.Clinical characteristics and management of cancer-associated acute venous thromboembolism：findings from he MASTER Registry［J］.Hawmatologica，2008，93(2)：273-278.
［10］Seddighzadeh A，Shetty R，Goldhaber SZ.Venous thromboembolism in patients with active cancer［J］.Thromb Haemost，2007，98(3)：656-661.
［11］Gao Lixia，Wu Kexiong，Hu Jun，et al.Clinical analysis of cancer patients with deep vein thrombosis［J］.Modern Oncololgy，2016，24（8）：1296-1299.［高丽霞，吴克雄，胡军，等.肿瘤患者合并深静脉血栓的临床分析［J］.现代肿瘤医学，2016，24（8）：1296-1299.］
［12］Yu Lianyou.Influencing factors of deep vein thrombosis in patients with cancer with bone metastases［J］.Chin J Lab Diagn，2016，20（3）：402-405.［于连有.癌症骨转移患者发生下肢深静脉血栓的影响因素研究［J］.中国实验诊断学，2016，20（3）：402-405.］
［13］Grommes J，von Trotha K，Wolf MD，et al.Catheter-directed thrombolysis in deep vein thrombosis：Which procedural measurement predicts outcome［J］.Phlebology，2014，29(1suppl)：135-139.
［14］Xue GH，Huang XZ，Ye M，et al.Catheteridirected thrombolysi and stenting in the treatment of iliac vein compression syndrome with acute iliofemoral deep vein thrombosis：outcome and follow-up［J］.Ann Vasc Srug，2014，28(4)：957-963.
［15］Sun Xiaolei，Wang Weiming，Zhang Lei，et al.Clinical analysis of inferior vena cava filter combined with antegrade catheter thrombolysis for acute lower extremity deep venous thrombosis(LEDVT)［J］.Sichuan Medical J，2016，37(9)：1030-1033.［孙晓磊，王伟明，张雷，等.下腔静脉滤器联合顺行置管溶栓在下肢急性深静脉血栓形成中的疗效分析［J］.四川医学，2016，37(9)：1030-1033.］
［16］Patterson BO，Hinchliffe R，Loftus IM，et al.Indications for catheter-directed thrombolysis in the management of acute proximal deep venous thrombosis［J］.Arterioscler Thromb Vasc Biol，2010，30：669-674.
［17］Vedantham S，Thorpe PE，Cardella JF，et al.Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with the use of endovascular thrombus removal［J］.J Vasc Interv Radiol，2009，20(Suppl 7)：S227-S239.